219 related articles for article (PubMed ID: 11349203)
1. Ratio of nuchal thickness to humerus length for Down syndrome detection.
Bahado-Singh RO; Oz U; Hsu CD; Deren O; Copel JA; Mahoney MJ
Am J Obstet Gynecol; 2001 May; 184(6):1284-8. PubMed ID: 11349203
[TBL] [Abstract][Full Text] [Related]
2. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk.
Bahado-Singh RO; Oz UA; Kovanci E; Deren O; Feather M; Hsu CD; Copel JA; Mahoney MJ
J Matern Fetal Med; 1999; 8(2):37-43. PubMed ID: 10090488
[TBL] [Abstract][Full Text] [Related]
3. A high-sensitivity alternative to "routine" genetic amniocentesis: multiple urinary analytes, nuchal thickness, and age.
Bahado-Singh R; Oz U; Kovanci E; Cermik D; Copel J; Mahoney MJ; Cole L
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):169-73. PubMed ID: 9914599
[TBL] [Abstract][Full Text] [Related]
4. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome.
Locatelli A; Piccoli MG; Vergani P; Mariani E; Ghidini A; Mariani S; Pezzullo JC
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):192-7. PubMed ID: 10649178
[TBL] [Abstract][Full Text] [Related]
5. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608
[TBL] [Abstract][Full Text] [Related]
6. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
[TBL] [Abstract][Full Text] [Related]
7. Nuchal thickness, urine beta-core fragment level, and maternal age for down syndrome screening.
Bahado-Singh RO; Oz AU; Flores D; Cermik D; Acuna E; Mahoney MJ; Cole L
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):491-5. PubMed ID: 9988824
[TBL] [Abstract][Full Text] [Related]
8. An alternative for women initially declining genetic amniocentesis: individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers.
Bahado-Singh R; Deren O; Oz U; Tan A; Hunter D; Copel J; Mahoney MJ
Am J Obstet Gynecol; 1998 Aug; 179(2):514-9. PubMed ID: 9731862
[TBL] [Abstract][Full Text] [Related]
9. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
10. Nuchal index: a gestational age independent ultrasound marker for the detection of Down syndrome.
Lim KI; Pugash D; Dansereau J; Wilson RD
Prenat Diagn; 2002 Dec; 22(13):1233-7. PubMed ID: 12478640
[TBL] [Abstract][Full Text] [Related]
11. Value of humerus length shortening for prenatal detection of Down syndrome in a Thai population.
Tannirandorn Y; Manotaya S; Uerpairojkit B; Tanawattanacharoen S; Wacharaprechanont T; Charoenvidhya D
J Obstet Gynaecol Res; 2002 Apr; 28(2):89-94. PubMed ID: 12078975
[TBL] [Abstract][Full Text] [Related]
12. Humeral shortening in second-trimester fetuses with Down syndrome.
Benacerraf BR; Neuberg D; Frigoletto FD
Obstet Gynecol; 1991 Feb; 77(2):223-7. PubMed ID: 1824870
[TBL] [Abstract][Full Text] [Related]
13. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
[TBL] [Abstract][Full Text] [Related]
14. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
15. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
[TBL] [Abstract][Full Text] [Related]
16. Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results.
Bahado-Singh RO; Tan A; Deren O; Hunter D; Copel J; Mahoney MJ
Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):824-9. PubMed ID: 8885729
[TBL] [Abstract][Full Text] [Related]
17. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
18. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
[TBL] [Abstract][Full Text] [Related]
19. The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters.
Lockwood CJ; Lynch L; Ghidini A; Lapinski R; Berkowitz G; Thayer B; Miller WA
Am J Obstet Gynecol; 1993 Nov; 169(5):1190-7. PubMed ID: 7694466
[TBL] [Abstract][Full Text] [Related]
20. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography.
Vintzileos AM; Egan JF
Am J Obstet Gynecol; 1995 Mar; 172(3):837-44. PubMed ID: 7892872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]